Interleukin-2, interleukin-15, and their roles in human natural killer cells

被引:246
|
作者
Becknell, B [1 ]
Caligiuri, MA
机构
[1] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA
[5] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源
关键词
D O I
10.1016/S0065-2776(04)86006-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are CD56(+)CD3(-) large granular lymphocytes that constitute a key component of the human innate immune response. In addition to their potent cytolytic activity, NK cells elaborate a host of immunoregulatory cytokines and chemokines that play a crucial role in pathogen clearance. Furthermore, interactions between NK and other immune cells are implicated in triggering the adaptive, or antigen-specific, immune response. Interleukin-2 (IL-2) and IL-15 are two distinct cytokines with partially overlapping properties that are implicated in the development, homeostasis, and function of NK cells. This review examines the pervasive effects of IL-2 and IL-15 on NK cell biology, with an emphasis on recent discoveries and lingering challenges in the field.
引用
收藏
页码:209 / 239
页数:31
相关论文
共 50 条
  • [1] Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells
    Leclercq, G
    Debacker, V
    DeSmedt, M
    Plum, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02): : 325 - 336
  • [2] Up-regulation of NKG2F receptor, a functionally unknown killer receptor, of human natural killer cells by interleukin-2 and interleukin-15
    Huang, Haihua
    Wang, Xin
    Zhang, Yukun
    Zheng, Xiaodong
    Wei, Haiming
    Sun, Rui
    ONCOLOGY REPORTS, 2010, 24 (04) : 1043 - 1048
  • [3] Interleukin-2 and interleukin-15: immunotherapy for cancer
    Fehniger, TA
    Cooper, MA
    Caligiuri, MA
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 169 - 183
  • [4] In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15
    Vuletic, Ana M.
    Jovanic, Irena P.
    Jurisic, Vladimir B.
    Milovanovic, Zorka M.
    Nikolic, Srdan S.
    Tanic, Nikola T.
    Konjevic, Gordana M.
    MELANOMA RESEARCH, 2015, 25 (01) : 22 - 34
  • [5] Interleukin-15 and Interleukin-2 Promote Persistence of FcεRIγ Negative (g-NK) Natural Killer Cells in Mice
    Masoumi, Shalaleh
    Bigley, Austin B.
    Spade, Shanae
    Sharif, Sana
    Spruill, Michelle
    Malik, Muhammad H.
    Yang, Luona
    Agha, Nadia
    Khalil, Mariam
    Babcock, Lyle
    Recker, Jenna
    Bates, Rachel
    Dipierro, Guy
    Liu, Xinli
    MOLECULAR THERAPY, 2023, 31 (04) : 413 - 413
  • [6] Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?
    Azzarone, B
    PottinClemenceau, C
    Krief, P
    Rubinstein, E
    Jasmin, C
    Scudeletti, M
    Indiveri, F
    EUROPEAN CYTOKINE NETWORK, 1996, 7 (01) : 27 - 36
  • [7] Cytotoxicity of Human Cord Blood Natural Killer Cells is Enhanced by Recombinant Interleukin-15
    Saghafi, Shiva
    Pourfathollah, Ali Akbar
    Kheirandish, Maryam
    Azimdoust, Anahita
    Behnia, Massoud
    Shahjahani, Mohammad
    Moin, Mostafa
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2010, 9 (02) : 69 - 77
  • [8] Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium
    Dann, SM
    Wang, HC
    Gambarin, KJ
    Actor, JK
    Robinson, P
    Lewis, DE
    Zucman, SC
    White, AC
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (07): : 1294 - 1302
  • [9] Human amniotic fluid lacks interleukin-2 and interleukin-15 but can interact with the β-chain of the interleukin-2 receptor
    Searle, RF
    Bromage, SJ
    Palmer, J
    Curry, JE
    Lang, AK
    IMMUNOLOGY, 2000, 99 (03) : 411 - 417
  • [10] Interleukin-15 responsiveness of interleukin-2 deficient mice.
    Lodolce, J
    Boone, D
    Dassopoulos, T
    Chai, S
    Trettin, S
    Ma, A
    GASTROENTEROLOGY, 1998, 114 (04) : A1024 - A1024